Autophagy-related polymorphisms predict hypertension in patients with metastatic colorectal cancer treated with FOLFIRI and bevacizumab: Results from TRIBE and FIRE-3 trials

PURPOSE: The most frequent bevacizumab-related side-effects are hypertension, proteinuria, bleeding and thromboembolism. To date, there is no biomarker that predicts anti-VEGF–associated toxicity. As autophagy inhibits angiogenesis, we hypothesised that single-nucleotide polymorphisms (SNPs) within...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Cancer
Main Authors: Berger, Martin D., Yamauchi, Shinichi, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Schirripa, Marta, Matsusaka, Satoshi, Yang, Dongyun, Groshen, Susan, Zhang, Wu, Ning, Yan, Okazaki, Satoshi, Miyamoto, Yuji, Suenaga, Mitsukuni, Lonardi, Sara, Cremolini, Chiara, Falcone, Alfredo, Heinemann, Volker, Loupakis, Fotios, Stintzing, Sebastian, Lenz, Heinz-Josef
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497847/
https://ncbi.nlm.nih.gov/pubmed/28347919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2017.02.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados